The US Food and Drug Administration said it found an additional "unexpected impurity" in three lots of Torrent Pharmaceuticals' recalled valsartan drug. The agency began testing the recalled products and the pills that have not been recalled for the substance after it learned that Zhejiang Huahai Pharmaceuticals found NDEA in several batches of its valsartan active ingredient. Not all batches have been found to be contaminated.

Intermountain Healthcare is teaming with the Mayo Clinic, HCA Healthcare and four others to form a non-profit company called Civica Rx to manufacture generic medicines. The effort is aimed at combating drug shortages and skyrocketing prices.

A landmark ruling against two leading drug companies could save the NHS "hundreds of millions" a year. Novartis and Bayer were trying to stop NHS doctors from prescribing a cheaper treatment for a serious eye condition. Health bosses said the judgement in the High Court may reduce the power of companies to set prices.

Government-backed agency Innovate UK is backing the £1m project, which is a collaboration between two small tech businesses and the Medicines Discovery Catapult, a government-run initiative. The project will see Optibrium, which creates software to improve the efficiency and productivity of drug discovery, and Intellegens, a spin out from the University of Cambridge, which is focused on the specific form of AI called ‘deep learning’, work with Medicines Discovery Catapult over the next two years.